AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD By: TalkMarkets July 30, 2024 at 07:15 AM EDT The AI-powered drug discovery process is expected to grow by a CAGR of 30% by 2030. Read More >> Related Stocks: AbCellera Biologics Inc. - Common Shares Absci Corporation - Common Stock Exscientia Plc - American Depositary Shares Recursion Pharmaceuticals, Inc. - Class A Common Stock Relay Therapeutics, Inc. - Common Stock Schrodinger, Inc. - Common Stock